Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
Takeda pays Keros $200M upfront for rival to BMS' booming blockbuster Reblozyl
Fierce Biotech
Tue, 12/3/24 - 11:00 am
Takeda
Keros Therapeutics
blood cancer
cancer
Reblozyl
Bristol Myers Squibb
GSK calls it quits on trade group BIO for 2025, following exits by Takeda, UCB and more
Fierce Pharma
Sun, 11/10/24 - 09:33 pm
GSK
BIO
Pfizer
Takeda
UCB Pharma
Japan's Takeda raises full-year profit forecast amid restructuring
MSN/Reuters
Thu, 10/31/24 - 10:47 pm
Takeda
earnings
restructuring
Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on
Fierce Pharma
Mon, 10/21/24 - 11:34 am
Takeda
layoffs
Massachusetts
Goodbye Wave: Takeda axes Huntington’s pact, freeing partner to pursue fresh pact
Fierce Biotech
Wed, 10/16/24 - 09:54 am
Takeda
Wave Life Sciences
Huntington's disease
After epilepsy setback, Ovid charges confidently ahead in CNS
Pharma Voice
Fri, 09/20/24 - 10:27 am
Ovid Therapeutics
R&D
Neuroscience
Takeda
US allows increased production of Takeda's ADHD drug to address shortage
Reuters
Wed, 09/4/24 - 11:35 am
Takeda
ADHD
Vyvanse
drug shortages
With a new oncology head, Takeda revamps its R&D strategy
Pharma Voice
Tue, 08/27/24 - 10:54 am
Takeda
R&D
oncology
Lundbeck leaves Trintellix to partner Takeda in the US, opting for royalties as it focuses efforts on Rexulti
Fierce Pharma
Wed, 07/31/24 - 11:16 pm
Lundbeck
Takeda
Trintellix
antidepressants
Rexulti
Takeda takes $140M charge on failed epilepsy drug, while touting continued FDA potential
Fierce Biotech
Wed, 07/31/24 - 10:53 am
Takeda
epilepsy
soticlestat
earnings
Takeda spinout HilleVax sees stock sink 80% as norovirus vaccine flunks phase 2 trial in infants
Fierce Biotech
Tue, 07/9/24 - 11:21 am
HilleVax
Takeda
norovirus
vaccines
clinical trials
Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster
Fierce Biotech
Mon, 07/8/24 - 11:54 am
Eli Lilly
Morphic
M&A
Takeda
Entyvio
IBD
Takeda to cut another 220 jobs in Massachusetts, while Merck KGaA plots its own layoffs
Fierce Pharma
Tue, 07/2/24 - 11:12 am
Takeda
Merck KGaA
layoffs
Massachusetts
Takeda reports positive data from Phase IIb trial of ITP treatment
Clinical Trials Arena
Mon, 06/24/24 - 11:18 am
Takeda
mezagitamab
TAK-079
ITP
clinical trials. dengvaxia
Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India
Reuters
Fri, 06/21/24 - 11:02 am
Takeda
Sun Pharma
Cipla
India
GERD
vonoprazan
Takeda flunks pivotal epilepsy tests but mulls path to market for Ovid-partnered prospect
Fierce Biotech
Mon, 06/17/24 - 11:29 am
Takeda
clinical trials
Ovid Therapeutics
Dravet syndrome
epilepsy
soticlestat
Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage
Fierce Pharma
Fri, 06/14/24 - 11:40 am
Takeda
Novartis
Ascentage Pharma
olverembatinib
CML
The 6 largest biopharma layoffs of 2024 so far
BioSpace
Wed, 06/12/24 - 11:59 am
layoffs
Bristol Myers Squibb
Bayer
Takeda
Pfizer
Novartis
Perrigo
Behind Big Pharma’s layoffs — is there an end in sight?
Pharma Voice
Tue, 06/11/24 - 11:22 am
layoffs
Big Pharma
Bristol Myers Squibb
Takeda
Novartis
Bayer
Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS
Clinical Trials Arena
Mon, 06/3/24 - 10:31 pm
Takeda
Pfizer
Adcetris
clinical trials
Hodgkin's lymphoma
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »